课题基金 / 基金详情

Characterisation of age and comorbidity-related defects in stem cell regenerative capacity during wound healing and adipose tissue engineering to facilitate clinical trials of tissue engineered breast reconstruction.

Characterisation of age and comorbidity-related defects in stem cell regenerative capacity during wound healing and adipose tissue engineering to facilitate clinical trials of tissue engineered breast reconstruction.
表征伤口愈合和脂肪组织工程过程中干细胞再生能力与年龄和合并症相关的缺陷,以促进组织工程乳房重建的临床试验。
批准号:
nhmrc : 1054472
负责人:
Mr Michael Findlay
金额:
$28.66万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2017-12-31

项目摘要

项目成果

Mr Michael Findlay的其他基金

相似基金

相关文献

中文摘要
翻译
尽管在实验动物身上成功地制造出了新的组织和器官,但人体组织工程仍然难以捉摸。新出现的证据表明,衰老和糖尿病等疾病会对人类干细胞的再生能力产生不利影响。在组织生成过程中描述衰老和疾病对干细胞的影响是逆转这些影响的第一步,为生产用于人体临床试验的新组织和器官铺平了道路。
英文摘要
Despite success with the production of new tissues and organs in laboratory animals, tissue engineering in humans remains elusive. Emerging evidence suggests that ageing and diseases such as diabetes can adversely affect human stem cell regenerative capacity. Characterizing the effects of ageing and disease on stem cells during tissue generation is the first step in reversing these effects, paving the way for the production of new tissues and organs for use in human clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of targeted therapies to reverse the effects of ageing and disease on wound healing and tissue generation
  • 批准号:
    nhmrc : GNT1054472
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $39.12万
  • 财政年份:
    2013
  • 负责人:
    Mr Michael Findlay
  • 依托单位:
Defining the differentiasome - exploring the determinants of cell differentiation in tissue flap prefabrication
  • 批准号:
    nhmrc : 310627
  • 项目类别:
    NHMRC Postgraduate Scholarships
  • 资助金额:
    $3.5万
  • 财政年份:
    2004
  • 负责人:
    Mr Michael Findlay
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
基于芍药甘草汤探寻AGEs-RAGE-P38 MAPK通路在高糖诱导软骨损伤中作用机制的研究
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位: